CERS - Cerus Corporation
NEXT EARNINGS:
Mar 2, 2026
(in 5 days)
EPS Est: $-0.01
|
Rev Est: $59.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.00
DETAILS
HIGH:
$5.00
LOW:
$3.00
MEDIAN:
$4.00
CONSENSUS:
$4.00
UPSIDE:
68.07%
Market Cap:
457.17M
Volume:
1,024,468
Avg Volume:
1,460,545
52 Week Range:
1.12-2.96
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.53
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
614
IPO Date:
1997-01-31
EPS (TTM):
-0.11
P/E Ratio:
-13.59
Revenue (TTM):
180.27M
Total Assets:
200.92M
Total Debt:
98.10M
Cash & Equiv:
20.27M
Rev Growth (5Y):
19.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-8.7%
Debt/Equity:
1.75
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.00 | $-0.02 | +99.5% | $52.7M | $59.3M | -11.1% |
| 2025-08-05 | $-0.03 | $-0.02 | -50.0% | $52.4M | $54.3M | -3.4% |
| 2025-05-01 | $-0.04 | $-0.05 | +20.0% | $43.2M | $47.4M | -8.9% |
| 2025-02-20 | $-0.01 | $-0.01 | 0.0% | $50.8M | $53.0M | -4.0% |
| 2024-10-30 | $-0.02 | $-0.01 | -33.3% | $46.0M | $50.7M | -9.2% |
| 2024-08-01 | $-0.03 | $-0.02 | -25.0% | $45.1M | $46.6M | -3.3% |
| 2024-05-02 | $-0.05 | $-0.05 | -7.1% | $38.4M | $41.1M | -6.7% |
| 2024-03-05 | $-0.01 | $-0.01 | -58.2% | $46.8M | $49.3M | -5.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 180.27M | 156.37M | 162.05M | 130.86M | 91.92M | 74.65M | 60.91M | 43.57M | 37.18M | 34.22M | 36.50M | 39.66M |
| Net Income | (20.92M) | (37.49M) | (42.78M) | (54.37M) | (59.86M) | (71.24M) | (57.56M) | (60.59M) | (62.91M) | (55.87M) | (38.57M) | (43.34M) |
| EPS | -0.11 | -0.21 | -0.24 | -0.32 | -0.37 | -0.51 | -0.44 | -0.56 | -0.62 | -0.58 | -0.52 | -0.64 |
| Total Assets | 200.92M | 197.75M | 218.09M | 237.50M | 221.41M | 165.53M | 163.46M | 98.24M | 103.48M | 139.47M | 81.77M | 83.38M |
| Total Debt | 98.10M | 96.00M | 87.24M | 87.59M | 66.89M | 64.45M | 29.87M | 29.80M | 19.38M | 19.87M | 9.87M | 3.37M |
| Cash & Equivalents | 20.27M | 11.65M | 35.59M | 48.76M | 36.59M | 34.99M | 28.86M | 13.68M | 22.56M | 71.02M | 22.78M | 29.48M |
| Operating Cash Flow | 11.36M | (43.17M) | (25.61M) | (33.92M) | (41.81M) | (65.50M) | (31.25M) | (52.23M) | (53.53M) | (51.13M) | (39.81M) | (26.80M) |
| Free Cash Flow | 8.52M | (47.77M) | (27.61M) | (34.83M) | (43.43M) | (74.43M) | (32.39M) | (52.59M) | (54.09M) | (51.85M) | (41.92M) | (27.46M) |
| FCF per Share | 0.05 | -0.26 | -0.16 | -0.20 | -0.26 | -0.53 | -0.25 | -0.49 | -0.53 | -0.54 | -0.56 | -0.41 |
| Book Value | 56.15M | 52.65M | 67.61M | 84.62M | 103.81M | 57.05M | 84.52M | 38.94M | 57.79M | 94.77M | 41.71M | 42.80M |
| Cash & ST Investments | 80.45M | 65.85M | 102.15M | 129.36M | 133.59M | 85.72M | 117.58M | 60.70M | 71.63M | 107.88M | 51.29M | 57.68M |
| ROC Equity | -0.37 | -0.71 | -0.63 | -0.64 | -0.58 | -1.25 | -0.68 | -1.56 | -1.09 | -0.59 | -0.92 | -1.01 |